Cabot (CBT) Stock Price Target 2026

The average analyst price target for Cabot is $88.80, 17.2% above the current price. Of 5 analysts, 1 rates it Buy, 3 Hold and 1 Sell. Targets range from $78 to $95. The latest change came on Nov 4, 2026, when Truist Securities lowered its price target on Cabot from $100 to $95 and kept a Buy rating.

The Average Analyst Price Target for Cabot is $88.80.

Price Target Range — 13 Quarters

Analyst Consensus — 5 Analysts

1Buy

3Hold

1Sell

Consensus RatingNeutral# Analysts5Avg. Consensus PT$88.80Upside to Avg. PT+17.2%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Cabot Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 4, 2026	Truist Securities	Peter Osterland	PT Cut	Buy	$100→$95
Oct 5, 2026	UBS	Joshua Spector	PT Cut	Neutral	$92→$86
Aug 7, 2026	JP Morgan	Jeffrey Zekauskas	PT Raise	Underweight	$70→$78
Aug 5, 2026	UBS	Joshua Spector	PT Cut	Neutral	$97→$92
Jun 25, 2026	Mizuho	John Roberts	PT Raise	Neutral	$80→$90
Jun 8, 2026	Truist Securities	Peter Osterland	Initiate	Buy	$98
May 13, 2026	JP Morgan	Jeffrey Zekauskas	PT Raise	Underweight	$68→$70
May 8, 2026	UBS	Joshua Spector	PT Raise	Neutral	$81→$86
May 6, 2026	Mizuho	John Roberts	PT Raise	Neutral	$75→$80
Feb 5, 2026	UBS	Joshua Spector	PT Raise	Neutral	$74→$81
Feb 5, 2026	Mizuho	John Roberts	Downgrade	Outperform→Neutral	$80→$75
Jan 12, 2026	UBS	Joshua Spector	PT Raise	Neutral	$65→$74
Dec 18, 2025	Mizuho	John Roberts	PT Raise	Outperform	$72→$80
Nov 28, 2025	JP Morgan	Jeffrey Zekauskas	PT Cut	Underweight	$75→$54
Nov 17, 2025	Mizuho	John Roberts	PT Cut	Outperform	$78→$72
Nov 5, 2025	UBS	Joshua Spector	PT Cut	Neutral	$82→$65
Oct 3, 2025	Mizuho	John Roberts	PT Cut	Outperform	$90→$88
Aug 5, 2025	UBS	Joshua Spector	PT Raise	Neutral	$81→$82
Apr 7, 2025	UBS	Joshua Spector	PT Cut	Neutral	$93→$83
Feb 21, 2025	JP Morgan	Jeffrey Zekauskas	PT Cut	Underweight	$105→$85